How does PI-RADS v2.1 impact patient classification? A head-to-head comparison between PI-RADS v2.0 and v2.1.

CONCLUSION: The most prominent change between v2.0 and v2.1 was observed in the TZ with the downgrading of typical benign prostatic hyperplasia nodules from category 2 into category 1. Overall, there were no significant changes in the number of positive and negative MRI results, with an expected low influence in clinical management. PMID: 32702998 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32702998?dopt=Abstract

Source: Acta Radiologica - July 22, 2020 Category: Radiology Authors: Linhares Moreira AS, De Visschere P, Van Praet C, Villeirs G Tags: Acta Radiol Source Type: research

More News: Benign Prostatic Hyperplasia | MRI Scan | Radiology | Study